GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vieworks Co 100120.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

27,850

-0.18%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩239.33bn

FY2016FY2025

Net income

₩21.97bn

FY2016FY2025

Free cash flow

₩7.79bn

FY2016FY2025

Shareholders' equity

₩249.61bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩239.33bn₩222.90bn₩220.25bn₩237.93bn₩193.14bn₩160.26bn₩136.01bn₩131.40bn₩123.46bn₩117.30bn
Gross profit₩100.89bn₩95.59bn₩95.29bn₩109.42bn₩95.69bn₩82.66bn₩71.93bn₩65.51bn₩62.08bn₩60.22bn
Research and development₩25.72bn₩26.07bn₩26.88bn₩22.79bn₩22.92bn₩22.30bn₩16.56bn₩16.09bn₩13.64bn₩11.34bn
Operating income₩21.42bn₩26.91bn₩18.11bn₩43.66bn₩34.81bn₩29.07bn₩26.43bn₩22.56bn₩28.63bn₩30.47bn
Net income₩21.97bn₩21.30bn₩14.71bn₩26.54bn₩33.47bn₩22.89bn₩24.22bn₩20.77bn₩19.63bn₩26.98bn
Diluted earnings per share2,553.172,319.401,602.582,890.323,645.642,422.922,457.272,106.271,952.752,703.97

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩351.89bn₩322.89bn₩292.67bn₩288.41bn₩240.84bn₩196.87bn₩181.01bn₩156.38bn₩137.64bn₩129.95bn
Cash and short-term investments—₩48.19bn₩45.13bn₩45.72bn₩45.42bn₩40.57bn₩65.66bn₩56.85bn₩37.30bn₩34.76bn
Total liabilities₩103.22bn₩86.10bn₩77.03bn₩79.21bn₩52.81bn₩26.62bn₩19.60bn₩15.58bn₩11.48bn₩19.61bn
Debt₩203.5m₩58.49bn₩52.69bn₩51.45bn₩22.42bn₩8.41bn₩2.27bn₩403.0m₩358.0m₩1.75bn
Shareholders' equity₩249.61bn₩236.96bn₩215.61bn₩209.20bn₩188.04bn₩170.25bn₩161.42bn₩140.80bn₩126.17bn₩110.34bn
Shares outstanding9m9m9m9m9m9m10m10m10m10m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩37.19bn₩35.58bn₩23.26bn−₩1.50bn₩16.17bn₩6.29bn₩18.68bn₩27.83bn₩18.85bn₩19.90bn
Capital spending−₩29.41bn−₩28.97bn−₩15.15bn−₩13.43bn−₩5.43bn−₩23.20bn−₩8.11bn−₩9.38bn−₩2.65bn−₩3.98bn
Free cash flow₩7.79bn₩6.62bn₩8.10bn−₩14.93bn₩10.73bn−₩16.92bn₩10.57bn₩18.45bn₩16.20bn₩15.91bn
Dividends paid−₩5.51bn−₩3.21bn−₩6.43bn−₩6.89bn−₩4.25bn−₩3.94bn−₩2.96bn−₩1.99bn−₩2.00bn−₩998.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue—₩58.17bn₩68.56bn₩53.67bn₩62.70bn₩54.40bn₩59.75bn₩48.38bn
Gross profit₩31.32bn₩27.92bn₩29.80bn₩21.83bn₩26.49bn₩22.78bn₩26.57bn₩20.56bn
Operating income₩10.70bn₩8.84bn₩8.53bn₩4.30bn₩6.53bn₩2.07bn₩5.95bn₩4.54bn
Net income₩16.40bn₩9.55bn₩10.84bn₩6.66bn₩2.13bn₩2.34bn₩9.24bn₩1.29bn
Diluted earnings per share1,906.241,109.521,259.12742.80237.73256.451,006.05140.13
Cash from operations—₩14.48bn₩10.70bn₩18.77bn−₩3.52bn₩11.23bn₩4.94bn₩14.88bn
Capital spending—−₩3.37bn−₩5.71bn−₩7.80bn−₩5.83bn−₩10.07bn−₩10.83bn−₩6.97bn
Free cash flow—₩11.10bn₩4.99bn₩10.98bn−₩9.35bn₩1.16bn−₩5.89bn₩7.92bn
Total assets₩367.99bn₩356.77bn₩351.89bn₩353.30bn₩339.03bn₩345.67bn₩322.89bn₩319.38bn
Cash and short-term investments—————₩60.89bn₩48.19bn₩64.74bn
Debt₩148.8m₩172.2m₩203.5m₩232.7m₩268.0m₩75.50bn₩56.92bn₩67.61bn
Shareholders' equity—₩243.89bn₩249.61bn₩237.48bn₩230.37bn₩232.44bn₩236.96bn₩226.90bn

Financial ratios

Data as of 4 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin42.2%42.9%43.3%46.0%49.5%51.6%———
Operating margin8.9%12.1%8.2%18.3%18.0%18.1%———
Net margin9.2%9.6%6.7%11.2%17.3%14.3%———
Return on equity8.8%9.0%6.8%12.7%17.8%13.4%———
Return on assets6.2%6.6%5.0%9.2%13.9%11.6%———
Free cash flow yield——————10.3%14.2%8.1%
Revenue growth7.4%1.2%-7.4%23.2%20.5%17.8%———
Earnings growth3.2%44.7%-44.6%-20.7%46.2%-5.5%———
Current ratio1.98x3.08x2.55x2.49x3.16x4.74x———
Debt to equity0.00x0.23x0.24x0.24x0.11x0.05x———
Equity ratio70.9%73.4%73.7%72.5%78.1%86.5%———
Interest coverage14.78x11.57x7.30x40.68x89.79x763.96x———
R&D as a share of sales10.7%11.7%12.2%9.6%11.9%13.9%———
Buybacks as a share of market value——————0.1%1.9%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.2%8.4%9.9%
Operating income-21.1%-5.9%2.2%
Net income-6.1%-0.8%3.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin42.5%43.6%45.5%47.0%
Operating margin10.5%12.0%13.7%16.0%
Net margin9.4%9.2%11.1%13.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings7.79.116.910.411.512.512.815.720.922.1
Price to sales0.70.91.11.22.01.82.32.53.35.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 Dec 2024.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year600.00350.00700.00750.00450.00400.00300.00200.00
  • 3-for-2 split · 19 Jul 2011

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.